Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics

Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics - Demonstrating Minicare

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON40913

Enrollment

765

Registered

2014-10-02

Start date

2015-09-09

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome myocardial infarction

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who undergo work up for chest pain Patients with elevated troponin concentration, e.g. after cardiac surgery

Exclusion criteria

Exclusion criteria: none, only foor the 99th percentile reference study, the following criteria are used (stated in 4.2.11) * Personal history of AMI or other cardiac diseases. * Subject with hypertension * Subject with known diabetes at the time of the enrollment. * Subject with known renal insufficiency at the time of the enrollment * Cardioactive drugs * Recreational drug use

Design outcomes

Primary

Measure	Time frame
In both work packages multiple outcome measures are defined. Please refer to the respective parts of the protocol. At the end of the study, the Minicare platform (hardware and software) and the troponin I test are in their final form and can undergo the CE marking process.	—

Secondary

Measure	Time frame
See study protocol	—

Countries

Netherlands

Outcome results